ImmuCell Corporation
NASDAQ: ICCC0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- NASDAQ Capital Market
- Sector
- Healthcare
- Industry
- Biotechnology
- CEO
- F. Olivier Te Boekhorst
- Employees
- 69
- Headquarters
- Portland, United States
- IPO year
- 1987
- Market cap
- $99.5M
- Website
- https://immucell.com
Loading ICCC…
Loading profile data…Frequently asked questions about ICCC
What does ImmuCell Corporation (ICCC) do?
ImmuCell Corporation functions as an animal health enterprise, specializing in the creation, manufacturing, and commercialization of offerings aimed at improving the vitality and output of dairy and beef cattle, serving both the U.S. domestic market and international regions. Among its key products is First Defense, an orally administered preven...
Where does ICCC trade?
ImmuCell Corporation (ICCC) trades on the NASDAQ Capital Market.
What sector is ICCC in?
ImmuCell Corporation (ICCC) operates in the Healthcare sector, specifically in the Biotechnology industry.
Who is the CEO of ImmuCell Corporation?
F. Olivier Te Boekhorst is the chief executive officer of ImmuCell Corporation (ICCC).
Where is ImmuCell Corporation headquartered?
ImmuCell Corporation is headquartered in United States.
Does ICCC pay a dividend?
ImmuCell Corporation (ICCC) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did ICCC go public?
ImmuCell Corporation (ICCC) completed its initial public offering in 1987.